An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...
A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...
Researchers from Memorial Sloan Kettering Cancer Center to present the latest advances in blood cancer during The American ...
Although he's been diagnosed with two types of metastatic cancer, Michael Simien feels well enough to ride his bike every day, including to appointments at MSK. To see Michael Simien darting in and ...
One of the MSK patients to benefit from this trial is Meryl Jacobs, who decided to participate after seeking a second opinion at MSK for treating stage 4 pancreatic cancer. Meryl, a psychotherapist ...
From life-saving medicine to gratitude for caregivers and a surprise romance, these stories remind us of the power of human connection.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Research at MSK Our research impact Research topics Core facilities & resources ...
En esta información se explica cómo tener una mutación en el gen FLCN puede afectarles a usted y a su familia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback